Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 10 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Mirum Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −7 vs. Q3 2022
- Shares held
- 33.3M
- −411.2K (−1.2%) vs. Q3 2022
- Total value
- $650.2M
- −$58.8M (−8.3%) vs. Q3 2022
- New holders
- 16
- 47 more added
- Sold out
- 23
- 25 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 326 | $8.36B |
| Q1 2026 | 311 | $6.29B |
| Q4 2025 | 284 | $4.82B |
| Q3 2025 | 272 | $4.20B |
| Q2 2025 | 214 | $2.82B |
| Q1 2025 | 214 | $2.44B |
| Q4 2024 | 205 | $2.19B |
| Q3 2024 | 178 | $2.08B |
| Q2 2024 | 161 | $1.83B |
| Q1 2024 | 172 | $1.34B |
| Q4 2023 | 187 | $1.48B |
| Q3 2023 | 159 | $1.55B |
| Q2 2023 | 146 | $955.6M |
| Q1 2023 | 117 | $832.9M |
| Q4 2022 | 104 | $650.2M |
| Q3 2022 | 112 | $709.1M |
| Q2 2022 | 110 | $569.4M |
| Q1 2022 | 99 | $590.4M |
| Q4 2021 | 86 | $395.7M |
| Q3 2021 | 73 | $465.0M |
| Q2 2021 | 67 | $404.6M |
| Q1 2021 | 61 | $463.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Mirum Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eventide Asset Management, LLC | 2,057,000 | $40.1M | 0.79% | +782,000+61.3% | Added |
| BlackRock Inc. | 2,136,677 | $41.7M | 0.00% | +387,328+22.1% | Added |
| Frazier Life Sciences Management, L.P. | 3,860,107 | $75.3M | 4.68% | +32,326+0.8% | Added |
| NEA Management Company, LLC | 4,186,243 | $81.6M | 4.59% | −1,5580.0% | Reduced |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −694,364−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −522,864−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −521,891−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −135,618−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −108,653−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −105,335−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −97,322−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −47,748−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −36,145−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −22,805−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −20,032−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −17,533−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −10,689−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −737−100.0% | Sold out |
| Almanack Investment Partners, LLC. | 0 | $0 | 0.00% | −634−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| FourThought Financial, LLC | – | – | – | – | Not filed |